Szio+

Name

Szio+

Legal name

Szio+ Inc.

Website

https://szioplus.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Dietary Supplements

NAICS

Food (Health) Supplement Retailers (456191), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

akta.pro secondary industries

Herbal & Botanical Supplements (CRADAGAD), Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI), Vitamins (A, B-Complex, C, D, E, K; Premixes) (AFAJAKAA)

Keywords

• Urinary tract supplements
• Natural UTI prevention
• Menopause relief supplements
• Women's health supplements
• Over-the-counter healthcare

Headquarters

HQ city

Pickering

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel

Core offering

Szio+ Inc. develops and sells clinically backed natural dietary supplements under its Utiva brand. Its flagship product, UTI Control, contains 36 mg of Proanthocyanidins (PACs) measured by the DMAC/A2 method for urinary tract infection prevention, and the line has been expanded with the Utiva Menopause Relief supplement, an all-natural, hormone-free alternative for menopause symptom relief. Products are sold across Canada and the United States and are recommended by physicians and pharmacists.

Product overview

Szio+ Inc. operates as a Canadian healthcare company developing and commercializing health supplements under the Utiva brand. The company's product portfolio centers on two core offerings: UTI Control, a flagship urinary tract infection prevention supplement containing Proanthocyanidins (PACs), and Utiva Menopause Relief, an all-natural hormone-free menopause symptom relief supplement. Both products are backed by clinical research and are available across Canada and the United States.

Differentiator

Problem solved

Functional benefit

Brands

• Utiva: Healthcare brand offering UTI prevention supplements and menopause relief products containing Proanthocyanidins (PACs) measured by DMAC/A2 method.

Products and services

• UTI Control Utiva's flagship dietary supplement for urinary tract infection prevention, containing 36 mg of Proanthocyanidins (PACs) measured by the DMAC/A2 method. It is positioned as a natural, drug-free, non-antibiotic preventive option for adult consumers prone to recurrent UTIs and is recommended by Canadian physicians and pharmacists.
• Utiva Menopause Relief An all-natural, hormone- and drug-free dietary supplement for menopause symptom relief, backed by multiple clinical trials and available to consumers in the United States and Canada. It targets women seeking non-hormonal alternatives for menopause-related symptoms.

Quantifiable outcome

• #1 physician-recommended and pharmacist-recommended brand in English Canada; #1 pharmacist-recommended brand in French Canada (2026 OTC Survey)

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Life Extension: Life Extension is a long-standing, clinically positioned supplement brand with cranberry and women's health products, serving as a broader incumbent in the same premium clinical-supplement category.
• Metagenics: Metagenics is a practitioner-channel supplement brand offering women's health and urinary tract products, comparable to Utiva in clinical positioning but operating through healthcare practitioners at a much larger scale.

Emerging players

• OPositiv: OPositiv is a women's wellness brand offering menopause support (MENO) among other products, competing for direct-to-consumer women's health dollars overlapping with Utiva's target consumer.

Direct peers

• Jarrow Formulas: Jarrow Formulas sells Fem-Dophilus and other specialty women's health and cranberry supplements, competing in the same specialty supplement category with practitioner and consumer channels.
• Ellura (Tao): Ellura markets high-PAC cranberry supplements specifically positioned for UTI prevention, directly competing with Utiva UTI Control on PAC dosage and clinical credibility.
• Bonafide Health: Bonafide is a digitally native, clinically positioned women's health brand with menopause and vaginal health products, competing for the same clinician-recommendation channel Utiva is building.
• Remifemin (Schaper & Brümmer / Nature's Way): Remifemin is a clinically studied botanical menopause supplement distributed in North America, directly competing with Utiva Menopause Relief on the all-natural, hormone-free positioning.
• Cystex: Cystex markets cranberry-based and symptom-relief UTI products, overlapping directly with Utiva's UTI franchise in retail pharmacy and online channels.
• Estroven (i-Health): Estroven is a leading OTC menopause symptom supplement brand in North America, directly competing with Utiva's newly launched Menopause Relief product.
• i-Health (AZO): i-Health's AZO brand is the most recognized OTC UTI prevention and symptom relief brand in North America, directly competing with Utiva's UTI Control for pharmacist recommendation and shelf placement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/Szioplus
• LinkedInlinkedin.com/company/szio-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Szio+